Metagenomi (MGX) analyst forecast and price target
Analyst forecast
Consensus of 5 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Wells Fargo | Maintained | Overweight | $7.00 from $9.00 | Aug 11, 2026 |
| Chardan Capital | Maintained | Buy | $5.00 from $7.00 | Jul 7, 2026 |
| Wells Fargo | Maintained | Overweight | $9.00 from $12.00 | May 12, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 | Aug 19, 2025 |
| Chardan Capital | Maintained | Buy | $11.00 from $12.00 | Aug 15, 2025 |
| Wells Fargo | Maintained | Overweight | $12.00 from $16.00 | Aug 14, 2025 |
| Chardan Capital | Maintained | Buy | $12.00 from $13.00 | May 15, 2025 |
| Wells Fargo | Maintained | Overweight | $16.00 from $20.00 | May 14, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 from $14.00 | Apr 3, 2025 |
| Wells Fargo | Maintained | Overweight | $20.00 from $25.00 | Mar 18, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $14.00 from $7.00 | Dec 10, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 | Nov 21, 2024 |
| Chardan Capital | Maintained | Buy | $15.00 | Nov 20, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 | Oct 15, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 | Sep 6, 2024 |
| Chardan Capital | Maintained | Buy | $15.00 | Sep 5, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 from $10.00 | Aug 21, 2024 |
| Chardan Capital | Maintained | Buy | $15.00 from $17.00 | Aug 19, 2024 |
| BMO Capital | Maintained | Outperform | $17.00 from $22.00 | Aug 15, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $10.00 | Jul 15, 2024 |
Frequently asked questions
Is MGX a buy, sell, or hold?
Analysts covering Metagenomi currently average a Buy rating: 4 buy, 1 hold and 0 sell, from 5 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on MGX?
On Aug 11, 2026, Wells Fargo maintained Metagenomi at Overweight with a price target of $7.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.